BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18793962)

  • 1. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
    Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cone beam CT-based adaptive intensity modulated proton therapy assessment using automated planning for head-and-neck cancer.
    Xu Y; Jin W; Butkus M; De Ornelas M; Cyriac J; Studenski MT; Padgett K; Simpson G; Samuels S; Samuels M; Dogan N
    Radiat Oncol; 2024 Jan; 19(1):13. PubMed ID: 38263237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy.
    Stuschke M; Kaiser A; Abu-Jawad J; Pöttgen C; Levegrün S; Farr J
    Radiat Oncol; 2013 Apr; 8():93. PubMed ID: 23601204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
    Lee TF; Liou MH; Ting HM; Chang L; Lee HY; Wan Leung S; Huang CJ; Chao PJ
    Sci Rep; 2015 Aug; 5():13165. PubMed ID: 26289304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatially fractionated radiotherapy (GRID) using helical tomotherapy.
    Zhang X; Penagaricano J; Yan Y; Liang X; Morrill S; Griffin RJ; Corry P; Ratanatharathorn V
    J Appl Clin Med Phys; 2016 Jan; 17(1):396-407. PubMed ID: 26894367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue.
    Press RH; Hu L; Huang S; Hasan S; Choi JI; Simone CB; Chhabra AM; Gelblum DY; Kabarriti R; Bakst RL; Cracchiolo JR; McBride SM; Lee NY
    Int J Part Ther; 2023; 9(4):253-260. PubMed ID: 37169010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose planned adaptive helical tomotherapy for cutaneous angiosarcoma of the scalp.
    Hama Y; Tsukamoto T; Tate E
    Strahlenther Onkol; 2024 Feb; 200(2):123-127. PubMed ID: 37264179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.
    van de Water TA; Bijl HP; Schilstra C; Pijls-Johannesma M; Langendijk JA
    Oncologist; 2011; 16(3):366-77. PubMed ID: 21349950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy.
    Camarda AM; Vincini MG; Russo S; Comi S; Emiro F; Bazani A; Ingargiola R; Vischioni B; Volpe S; Orecchia R; Jereczek-Fossa BA; Orlandi E; Alterio D
    Tumori; 2024 May; ():3008916241252544. PubMed ID: 38769916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Framework for Thermoradiotherapy Treatment Planning.
    Ödén J; Eriksson K; Pavoni B; Crezee H; Kok HP
    Int J Radiat Oncol Biol Phys; 2024 Feb; ():. PubMed ID: 38387812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early experience of helical tomotherapy for hepatobiliary radiotherapy.
    Massabeau C; Marchand V; Zefkili S; Servois V; Campana F; Giraud P
    Case Reports Hepatol; 2011; 2011():545267. PubMed ID: 25954545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy.
    Wu CC; Chen MS; Chen JY
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The top 100 most cited articles in helical tomotherapy: a scoping review.
    Zhang Y; Rong L; Wang Z; Zhao H
    Front Oncol; 2023; 13():1274290. PubMed ID: 37916164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of an
    Mori M; Deantoni C; Olivieri M; Spezi E; Chiara A; Baroni S; Picchio M; Del Vecchio A; Di Muzio NG; Fiorino C; Dell'Oca I
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1329-1336. PubMed ID: 36604325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer.
    Cheon W; Jeong S; Jeong JH; Lim YK; Shin D; Lee SB; Lee DY; Lee SU; Suh YG; Moon SH; Kim TH; Kim H
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges.
    Nuyts S; Bollen H; Ng SP; Corry J; Eisbruch A; Mendenhall WM; Smee R; Strojan P; Ng WT; Ferlito A
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision.
    Vai A; Molinelli S; Rossi E; Iacovelli NA; Magro G; Cavallo A; Pignoli E; Rancati T; Mirandola A; Russo S; Ingargiola R; Vischioni B; Bonora M; Ronchi S; Ciocca M; Orlandi E
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Craniospinal Irradiation - The implementation and Use of Normal Tissue Complication Probability in Comparing Photon versus Proton Planning.
    Balasubramanian S; Shobana MK
    J Med Phys; 2021; 46(4):244-252. PubMed ID: 35261494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution.
    Williams VM; Parvathaneni U; Laramore GE; Aljabab S; Wong TP; Liao JJ
    Int J Part Ther; 2021; 8(2):28-40. PubMed ID: 34722809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.